AU2002332130A1 - Msrebps as modifiers of the srebp pathway and methods of use - Google Patents

Msrebps as modifiers of the srebp pathway and methods of use

Info

Publication number
AU2002332130A1
AU2002332130A1 AU2002332130A AU2002332130A AU2002332130A1 AU 2002332130 A1 AU2002332130 A1 AU 2002332130A1 AU 2002332130 A AU2002332130 A AU 2002332130A AU 2002332130 A AU2002332130 A AU 2002332130A AU 2002332130 A1 AU2002332130 A1 AU 2002332130A1
Authority
AU
Australia
Prior art keywords
msrebps
modifiers
methods
srebp pathway
srebp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002332130A
Inventor
Glenn R. Hammonds Jr.
Lisa C. Kadyk
Eric C. Kong
Carol L. O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of AU2002332130A1 publication Critical patent/AU2002332130A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
AU2002332130A 2001-10-16 2002-10-15 Msrebps as modifiers of the srebp pathway and methods of use Abandoned AU2002332130A1 (en)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US32989001P 2001-10-16 2001-10-16
US60/329,890 2001-10-16
US34228801P 2001-12-21 2001-12-21
US34228701P 2001-12-21 2001-12-21
US60/342,287 2001-12-21
US60/342,288 2001-12-21
US34809602P 2002-01-14 2002-01-14
US60/348,096 2002-01-14
US35140102P 2002-01-25 2002-01-25
US35140302P 2002-01-25 2002-01-25
US35136102P 2002-01-25 2002-01-25
US60/351,401 2002-01-25
US60/351,403 2002-01-25
US60/351,361 2002-01-25
US35882602P 2002-02-21 2002-02-21
US60/358,826 2002-02-21
US36861502P 2002-03-27 2002-03-27
US60/368,615 2002-03-27
PCT/US2002/032807 WO2003033656A2 (en) 2001-10-16 2002-10-15 MSREBPs AS MODIFIERS OF THE SREBP PATHWAY AND METHODS OF USE

Publications (1)

Publication Number Publication Date
AU2002332130A1 true AU2002332130A1 (en) 2003-04-28

Family

ID=27578812

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002332130A Abandoned AU2002332130A1 (en) 2001-10-16 2002-10-15 Msrebps as modifiers of the srebp pathway and methods of use

Country Status (2)

Country Link
AU (1) AU2002332130A1 (en)
WO (1) WO2003033656A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201815709T4 (en) 2011-12-22 2018-11-21 Hoffmann La Roche Ion exchange membrane chromatography.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527690A (en) * 1987-03-30 1996-06-18 Board Of Regents, The University Of Texas System Methods and compositions relating to sterol regulatory element binding proteins
US6322962B1 (en) * 1998-08-14 2001-11-27 Board Of Regents, The University Of Texas System Sterol-regulated Site-1 protease and assays of modulators thereof

Also Published As

Publication number Publication date
WO2003033656A2 (en) 2003-04-24
WO2003033656A3 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
AU2002310256A1 (en) Ppp2cs as modifiers of the p53 pathway and methods of use
AU2003224638A1 (en) PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
EP1421384A4 (en) Hprp4s as modifiers of the p53 pathway and methods of use
AU2002314474A1 (en) Grating structures and methods of making the grating structures
AU2002314466A1 (en) Withasol and methods of use
AU2002314887A1 (en) Gads as modifiers of the p53 pathway and methods of use
AU2002316631A1 (en) Ube2s as modifiers of the p21 pathway and methods of use
AU2002332130A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
AU2003295881A1 (en) Lamps as modifiers of the p53 pathway and methods of use
AU2003303094A1 (en) MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2002361654A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003215004A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
AU2003274911A1 (en) Mrbs as modifiers of the rb pathway and methods of use
AU2002303947A1 (en) Pecis as modifiers of the p53 pathway and methods of use
AU2002303951A1 (en) Glras as modifiers of the p53 pathway and methods of use
AU2002312283A1 (en) Srpks as modifiers of the p53 pathway and methods of use
AU2002345486A1 (en) Slc13as as modifiers of the p53 pathway and methods of use
AU2002357817A1 (en) Klcs as modifiers of the p53 pathway and methods of use
AU2002314874A1 (en) Modifiers of the p53 pathway and methods of use
AU2003213665A1 (en) Lgals as modifiers of the chk pathway and methods of use
AU2003213693A1 (en) MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
AU2002337915A1 (en) Ctsls as modifiers of the p53 and apaf-1 pathways and methods of use
EP1578945A3 (en) Cct6s as modifiers of the rb pathway and methods of use
AU2003294499A1 (en) Rhebs as modifiers of the rb pathway and methods of use
AU2002354668A1 (en) Modifiers of the p21 pathway and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase